• 1
    Abercrombie E.D. & Finlay J.M. (1991) Monitoring extracellular norepinephrine in brain using in vivo microdialysis and HPLCEC, in Microdialysis in the Neurosciences (Robinson T. E. and Justice J. B. Jr., eds), pp. 253274. Elsevier, Amsterdam.
  • 2
    Abercrombie E.D. & Zigmond M.J. (1990) In vivo neurochemical analysis of exogenously administered L-DOPA: implications for treatment of Parkinson’s disease, in Basal Ganglia, Vol. III (Bernardi G., Carpenter M. B., and Di Chiara G., eds), pp. 673682. Plenum Press, New York.
  • 3
    Abercrombie E.D., Bonatz A.E., Zigmond M.J. (1990) Effects of L-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Res. 525 3644.
  • 4
    Acquas E., Carboni E., De Ree R.H.A., Da Prada M., Di Chiara G. (1992) Extracellular concentrations of dopamine and metabolites in the rat caudate after oral administration of a novel catechol-O-methyltransferase inhibitor Ro 40-7592. J. Neurochem. 59 326330.
  • 5
    Arai R., Karasawa N., Nagatsu I. (1996) Aromatic L-amino acid decarboxylase is present in serotonergic fibers of the striatum of the rat: a double-labeling immunofluorescence study. Brain Res. 706 177179.
  • 6
    Bunney B.S., Aghajanian G.K., Roth R.H. (1973) Comparison of effects of L-DOPA, amphetamine and apomorphine on firing rate of rat dopaminergic neurones. Nat. New Biol. 245 123125.
  • 7
    De Boer P., Wachtel S.R., Abercrombie E.D. (1994) Biochemistry and pharmacology of L-DOPA in relation to basal ganglia circuitry, in Basal Ganglia, Vol. IV (Percheron G., McKenzie J. S., and Feger J., eds), pp. 395401. Plenum Press, New York.
  • 8
    Garris P.A. & Wightman R.M. (1994) Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study. J. Neurosci. 14 442450.
  • 9
    Hefti F., Melamed E., Wurtman R.J. (1981) The site of dopamine formation in rat striatum after L-DOPA administration. J. Pharmacol. Exp. Ther. 217 189197.
  • 10
    Hollister A.S., Breese G.R., Mueller R.A. (1979) Role of monoamine neuronal systems in L-dihydroxyphenylalanine-stimulated activity. J. Pharmacol. Exp. Ther. 208 3743.
  • 11
    Kang U.J., Park D.H., Wessel T., Baker H., Joh T.H. (1992) DOPA-decarboxylation in the striata of rats with unilateral substantia nigra lesions. Neurosci. Lett. 147 5357.
  • 12
    Koshimura K., Ohue T., Akiyama Y., Itoh A., Miwa S. (1992) L-DOPA administration enhances exocytotic dopamine release in vivo in the rat striatum. Life Sci. 51 747755.
  • 13
    Li X., Juorio A.V., Paterson I.A., Waltz W., Zhu M., Boulton A.A. (1992) Gene expression of aromatic L-amino acid decarboxylase in cultured rat glial cells. J. Neurochem. 59 11721175.
  • 14
    Lloyd K.G., Davidson L., Hornykiewicz O. (1975) The neurochemistry of Parkinson’s disease: effect of L-DOPA therapy. J. Pharmacol. Exp. Ther. 195 453464.
  • 15
    Melamed E. (1988) Mechanism of action of exogenous L-DOPA: is it a physiological therapy for Parkinson’s disease, in Parkinson’s Disease and Movement Disorders (Jankovic J. and Tolosa E., eds), pp. 8794. Urban and Schwarzenberg, Baltimore.
  • 16
    Melamed E., Hefti F., Wurtman R.J. (1980) Nonaminergic striatal neurons convert exogenous L-DOPA to dopamine in parkinsonism. Ann. Neurol. 8 558563.
  • 17
    Melamed E., Hefti F., Pettibone D.J., Liebman J., Wurtman R.J. (1981) Aromatic L-amino acid decarboxylase in rat corpus striatum: implications for action of L-DOPA in parkinsonism. Neurology 31 651655.
  • 18
    Miller D.W. & Abercrombie E.D. (1998) 5-HT terminals as primary source of extracellular dopamine formed from exogenous L-DOPA in striatum of 6-OHDA-treated rats. Soc. Neurosci. Abstr. 24 1989.
  • 19
    Nakazato T. & Akiyama A. (1992) Decarboxylation of exogenous L-3,4-dihydroxyphenylalanine in rat striatum as studied by in vivo voltammetry. J. Neurochem. 58 121127.
  • 20
    Ng K.Y., Chase T.N., Colburn R.W., Kopin I.J. (1972) L-DOPA in parkinsonism: a possible mechanism of action. Neurology 22 688696.
  • 21
    Nicholson C. & Rice M.E. (1991) Diffusion of ions and transmitters in the brain cell microenvironment, in Volume Transmission in the Brain: Novel Mechanisms for Neural Transmission (Fuxe K. and Agnate L. F., eds), pp. 279294. Raven Press, New York.
  • 22
    Nissbrandt H., Engberg G., Pileblad E. (1991) The effects of GBR-12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra. Naunyn Schmiedebergs Arch. Pharmacol. 344 1628.
  • 23
    Paxinos G. & Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, Orlando.
  • 24
    Schoenfeld R.I. & Uretsky N.J. (1973) Enhancement by 6-hydroxydopamine of the effects of DOPA upon the motor activity of rats. J. Pharmacol. Exp. Ther. 186 616624.
  • 25
    Trugman J.M. & Wooten G.F. (1986) The effects of L-DOPA on regional cerebral glucose utilization in rats with unilateral lesions of the substantia nigra. Brain Res. 379 264274.
  • 26
    Wachtel S.R. & Abercrombie E.D. (1994) L-3,4-Dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors. J. Neurochem. 63 108117.
  • 27
    Yahr M.D., Wolf A., Antunes J., Miyoshi K., Duffy P. (1972) Autopsy findings in parkinsonism following treatment with levodopa. Neurology 20 (Suppl.) , 5671.
  • 28
    Zetterström T., Herrera-Marschitz M., Ungerstedt U. (1986) Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis. Brain Res. 376 17.